Now to these markets…I got this from my girl BrynTalkington the other day. I hope she and Thomas (Tom) Lee (not drummer) FSInsight.com are right because I doubled down this morning. #tech #banks #fintech #WallStreet

Flaskworks patent application status "Mail Notice of Allowance" on April 27, 2022: US17/074,94 - Systems and Methods for Cell Culturing. As usual, now all that's left is paying the issue fee to seal the patent issuance. #Flaskworks $NWBO patentscope.wipo.int/search/en/deta… Michael Bigger

Huge news! PIP is required for approval. The path was unclear to some investors (and some experts) due to the fact that the trial start predated the law. It’s clear now, PIP approved. $NWBO prnewswire.com/news-releases/…

‘Spoofing’ case might draw back curtain on high-speed trading firms on.ft.com/4c19YKE | opinion

$NWBO I have just published a new report on the lawsuit. It can be accessed at this link. smithonstocks.com/denial-of-the-… Ignore the message that you need to subscribe to access the report. It is free.

Massive $nwbo tree shake from the bell. So obvious with no news. Went down -12% in first 30mins now -5% back to $0.28

$SABR Delivered revenue growth of 3% YoY or $24M to $765M. Achieved Q3 AEBITDA Generated $8M of free cash flow in Q3 Ended Q3’24 with $690M cash on balance sheet Expect to deliver positive free cash flow in Q4 and for full year 2024

Trump nominated JF Kennedy's nephew - an alternative to medicine and a critic to the pharma industry inc. the FDA. "1. preserve your records and 2. pack your bags". A blessing for $nwbo

Claire, aka Midwestern Hedgie 🏳️‍⚧️ Yeah, nothing to see here. You were only live tweeting false information while the top line data was released that just so happened to be the biggest single manipulation day on record. Nothing to see here, right? Andrew Tobias x.com/hoffmann6383/s…

MHRAgovuk #dcvax $nwbo #gbm With a totally benign safet profile and proven efficacy DCVax is a no-brainer ) 🤣excuse the pun. as this AI Analysis shows with a compare and contrast analysis GPT-4o (Poe) When comparing the safety profiles of DCVax (a dendritic cell-based cancer vaccine)

$CLPT ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results accessnewswire.com/newsroom/en/bi…

$NIKE Q3 EPS $0.54 VS. $0.29 ESTIMATE, NET INCOME $794M BEATS $424.2M ESTIMATE, PRETAX PROFIT $844M TOPS $523.3M ESTIMATE; REVENUE $11.27B EXCEEDS $11.01B ESTIMATE; GROSS PROFIT $4.68B, GROSS MARGIN 41.5%

$OSCR is a health insurance disruptor set to 5x Member numbers are exploding, revenue growth is unbelievable, and profits are soaring. Here is my $OSCR Investment Thesis:🧵

$TDMX 🫀 🏥 👨‍⚕️ Organs-as-a-Service Medical technology company! - Innovative Products - Huge TAM in the US - Expansion to the EU is ongoing - Growing Profits Full report 🌐👇

8/ Exploding Services Revenue $TDMX Organ-as-a-Services offering is delivering impeccable results! Services revenue has exploded $0 ➡️ $187M in just 4 years! This is 4x faster than product sales growth.

$nwbo - Cancer breakthroughs mean disease ‘no longer a death sentence’ thetimes.com/article/2787e5…

Added 1000 $clpt at 10.55

$TMDX (TransMedics) #earnings are out:

$clpt $9.2m revenue +17% YoY increase. $105m note arrangement. +33% revenue to $3.4m for PRISM. 60% gross margin v 63% YoY $41.5m cash Full year guidance $36-41m Net loss $5.8m v $4.4m YoY

$QURE Announces Positive Topline Results from Pivotal Phase I/II Study of AMT-130 in Patients with Huntington’s Disease. Pivotal study met primary endpoint; high-dose AMT-130 demonstrated statistically significant 75% disease slowing at 36 months as measured by cUHDRS compared